Bliss GVS Pharma Ltd BLISSGVS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 109.55
- Day Range
- INR 106.15–110.75
- 52-Week Range
- INR 70.85–149.60
- Bid/Ask
- INR 109.95 / INR 110.25
- Market Cap
- INR 11.51 Bil
- Volume/Avg
- 231,247 / 659,259
Key Statistics
- Price/Earnings (Normalized)
- 12.99
- Price/Sales
- 1.51
- Dividend Yield (Trailing)
- 0.45%
- Dividend Yield (Forward)
- 0.45%
- Total Yield
- 0.45%
Company Profile
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Geographically, it derives a majority of revenue from Outside India. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 763
- Website
- https://www.blissgvs.com
Comparables
Valuation
|
Metric
|
BLISSGVS
|
500288
|
506943
|
|---|---|---|---|
Price/Earnings (Normalized) | 12.99 | 30.40 | 53.64 |
Price/Book Value | 1.19 | 2.95 | 10.25 |
Price/Sales | 1.51 | 1.41 | 8.37 |
Price/Cash Flow | 8.14 | 28.83 | 40.71 |
Price/Earnings
BLISSGVS
500288
506943
Financial Strength
|
Metric
|
BLISSGVS
|
500288
|
506943
|
|---|---|---|---|
Quick Ratio | 3.97 | 0.95 | 1.81 |
Current Ratio | 5.08 | 2.23 | 2.74 |
Interest Coverage | 17.91 | 30.56 | 15.51 |
Quick Ratio
BLISSGVS
500288
506943
Profitability
|
Metric
|
BLISSGVS
|
500288
|
506943
|
|---|---|---|---|
Return on Assets (Normalized) | 8.07% | — | — |
Return on Equity (Normalized) | 10.38% | — | — |
Return on Invested Capital (Normalized) | 9.49% | — | — |
Return on Assets
BLISSGVS
500288
506943
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Jszsfzjzn | Krpz | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Vgjqbjlgqg | Mftskf | $72.9 Bil | |
HLN
| Haleon PLC ADR | Qthzybdfq | Mbwg | $37.5 Bil | |
VTRS
| Viatris Inc | Mspktsw | Ygf | $13.3 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qygtxdxz | Kyjp | $11.7 Bil | |
CTLT
| Catalent Inc | Vhbrjvbny | Dgnyryl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rrjjdfjxh | Zyqw | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Kddpmyjm | Sfx | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Wjydvql | Ltsyfh | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Fxmnhlcky | Xjs | $3.0 Bil |